Mink Therapeutics Inc (INKT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2021 | 09-2021 | 06-2021 | 03-2021 | 12-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -30,213 | -24,448 | -10,181 | -3,846 | -16,239 |
| Depreciation Amortization | 78 | 54 | 34 | 16 | 55 |
| Accounts payable and accrued liabilities | -152 | -1,505 | -891 | -307 | N/A |
| Other Working Capital | 3,736 | 414 | -196 | -721 | 1,477 |
| Other Operating Activity | 13,724 | 14,360 | 3,605 | 649 | 6,369 |
| Operating Cash Flow | $-12,827 | $-11,125 | $-7,629 | $-4,209 | $-8,338 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -249 | -249 | -137 | -40 | -95 |
| Investing Cash Flow | $-249 | $-249 | $-137 | $-40 | $-95 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 9,459 | 9,459 | 6,677 | 2,325 | N/A |
| Common Stock Issued | 39,798 | 0 | N/A | N/A | N/A |
| Other Financing Activity | 0 | 0 | 0 | 0 | 11,106 |
| Financing Cash Flow | $49,257 | $9,460 | $6,677 | $2,325 | $11,106 |
| Exchange Rate Effect | 17 | 43 | 57 | 43 | -281 |
| Beginning Cash Position | 2,691 | 2,691 | 2,691 | 2,691 | 299 |
| End Cash Position | 38,889 | 820 | 1,658 | 810 | 2,691 |
| Net Cash Flow | $36,198 | $-1,872 | $-1,033 | $-1,881 | $2,392 |
| Free Cash Flow | |||||
| Operating Cash Flow | -12,827 | -11,125 | -7,629 | -4,209 | -8,338 |
| Capital Expenditure | -249 | -249 | -137 | -40 | N/A |
| Free Cash Flow | -13,076 | -11,374 | -7,766 | -4,248 | -8,338 |